Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy Disease Characteristics

Read about the disease characteristics for a current clinical trial being conducted to study the effects of Immunotoxin Therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Disease Characteristics:
• Histologically confirmed epithelial pleural mesothelioma not amenable to potentially curative surgical resection
o Unresectable disease, defined as any 1 of the following:
Metastatic disease
Patient found at surgery not to be amenable to resection
Not to benefit from surgery due to extensive local disease or not a surgical candidate due to comorbid medical conditions as deemed by a qualified oncologist
• Measurable disease
• No documented and ongoing CNS involvement with malignant disease (history of CNS involvement is not an exclusion criterion)

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney